These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33461143)

  • 1. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
    Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells.
    Wang Z; Sun X; Feng Y; Liu X; Zhou L; Sui H; Ji Q; E Q; Chen J; Wu L; Li Q
    Anticancer Drugs; 2017 Mar; 28(3):281-288. PubMed ID: 27997436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydromyricetin promotes apoptosis, suppresses proliferation and tumor necrosis factor-α-mediated nuclear factor kappa-B activation in nasopharyngeal carcinoma CNE-2 cell.
    Li CH; Ding H; Shi JL; Huang B; Ding H; Lin HG; Zeng JC; Zhao Y; Luo GQ
    J Tradit Chin Med; 2021 Jun; 41(3):367-375. PubMed ID: 34114393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
    Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
    J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Jianpi Jiedu Recipe on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer.
    Sui H; Zhu HR; Wu J; Nikitin AY; Cai JF; Fan ZZ; Li Q
    Chin J Integr Med; 2014 Aug; 20(8):610-7. PubMed ID: 23543356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells.
    Wu M; Jiang M; Dong T; Xu L; Lv J; Xue M; Huang M
    Asian Pac J Cancer Prev; 2020 May; 21(5):1269-1274. PubMed ID: 32458632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer.
    Sui H; Zhou LH; Zhang YL; Huang JP; Liu X; Ji Q; Fu XL; Wen HT; Chen ZS; Deng WL; Zhu HR; Li Q
    J Cell Biochem; 2016 Jun; 117(6):1471-81. PubMed ID: 26590365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line.
    Zhang C; He LJ; Ye HZ; Liu DF; Zhu YB; Miao DD; Zhang SP; Chen YY; Jia YW; Shen J; Liu XP
    Mol Med Rep; 2018 Dec; 18(6):5409-5416. PubMed ID: 30365132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.
    Xu X; Zhang X; Zhang Y; Yang L; Liu Y; Huang S; Lu L; Kong L; Li Z; Guo Q; Zhao L
    Sci Rep; 2017 Feb; 7():39950. PubMed ID: 28150717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R; Fang C; Xu J; Tan H; Li P; Ma L
    Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
    Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
    J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway.
    Wu JJ; Zhu YF; Guo ZZ; Lou YM; He SG; Guan Y; Zhu LJ; Liu ZQ; Lu LL; Liu L
    Phytomedicine; 2018 May; 44():87-97. PubMed ID: 29277460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1.
    Yang R; Song C; Chen J; Zhou L; Jiang X; Cao X; Sun Y; Zhang Q
    Phytomedicine; 2020 Apr; 69():153211. PubMed ID: 32259676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.
    Jiang L; Wang P; Sun YJ; Wu YJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):265. PubMed ID: 31215501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
    Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
    Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
    Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
    Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway.
    Luo Y; Lu S; Dong X; Xu L; Sun G; Sun X
    Apoptosis; 2017 Aug; 22(8):1013-1024. PubMed ID: 28612103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (2R,3R)Dihydromyricetin inhibits osteoclastogenesis and bone loss through scavenging LPS-induced oxidative stress and NF-κB and MAPKs pathways activating.
    Zhang X; Li X; Fang J; Hou X; Fang H; Guo F; Li F; Chen A; Huang S
    J Cell Biochem; 2018 Nov; 119(11):8981-8995. PubMed ID: 30076654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal of chemoresistance to vincristine in gastric cancer cells by NF-kappaB inhibitor].
    Wang W; Luo HS
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):335-8. PubMed ID: 16117894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.